3D Tissue Models

Hepatology: Genentech

Total Score People Score Events Score
13 12 10
Date Event Presentation Speakers
October 28, 2013 Tumor Immunology and Immunotherapy Oncology meets immunology: targeting PD-L1 in combination Ira Mellman
May 31, 2013 ASCO Annual Meeting 2013 The Many Faces of Hepatocellular Carcinoma: From Biology to Treatment Robert Kelley
April 6, 2013 AACR Annual Meetings Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Domagoj Vucic
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Peter K Jackson
August 3, 2009 The Next Wave of Antibody Therapeutics Antibody-Drug Conjugates for Cancer Therapy Paul G. Polakis
Clinical Results of the Phase I and Phase II Studies of Trastuzumab-DM1, A First-in-class HER2 Antibody-Drug Conjugate, in Patients with HER2+ Metastatic Breast Cancer Barbara Klencke
June 8, 2009 RNAi for Functional Screens Probing the p53 Pathway Laura Corson
April 28, 2008 Clinical Development of Therapeutic Antibodies The Development of Antiangiogenics in Lung Cancer Jane Huang
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE The role of Neuropilin-2 in tumor lymphangiogenesis Anil Bagri
February 10, 2008 GRC - Plasminogen Activation & Extracellular Proteolysis The transmembrane serine protease hepsin activates pro-hepatocyte growth factor (HGF) and pro-urokinase plasminogen activator (uPA) and promotes tumor progression Daniel Kirchhofer
November 7, 2007 Antibodies Europe: Engineering the Next Generation of Antibodies Nov (07-08) Engineering Therapeutics (10:00-11:30) Robert Kelley
Engineering Therapeutics: Fc Engineering of Therapeutic Antibodies (10:00-10:30) Robert Kelley
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 7: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part II) (09:00-12:00) Mark S. Dennis
Session 7: Tumor Targeting with an AB.Fab (09:00-09:20) Mark S. Dennis
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.